Notice of Expiration of RFA-HL-20-014 "Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)"

Notice Number: NOT-HL-20-756

Key Dates
Release Date: March 18, 2020

Related Announcements
 RFA-HL-20-014

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

This Notice is to inform the research community that NHLBI will expire RFA-HL-20-014 "Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)" effective immediately. Potential applicants are advised to regularly check the NIH Guide and/or the NHLBI web page for related funding opportunity announcements.

This will eliminate the FOA’s final application due date of June 17, 2020.

Currently Reads:
Expiration Date: June 18, 2020

Modified to read:
Expiration Date: March 18, 2020

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Division of Blood Diseases and Resources
Andrei Kindzelski, MD, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: kindzelskial@nhlbi.nih.gov

Division of Cardiovascular Sciences
Michelle Olive, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-443-7933
Email: michelle.olive@nih.gov

Division of Lung Diseases
Lora Reineck, M.D., M.S.
N?ational Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0222
Email: lora.reineck@nih.gov